Press Releases

NEW YORK, March 23, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced it has reached an agreement with Voltron Therapeutics, Hoth Therapeuticsto form a joint venture entity (to be named HaloVax) to commence preclinical studies for the development of vaccine prospects to prevent, intercept or tre

Panaxia Israel has just imported from the US hemp extracts from which it will manufacture CBD-rich cannabis productsEssence extraction was conducted in a facility jointly operated by Panaxia and Ultra Health located in New Mexico, USDr. Dadi Segal, Panaxia CEO: "We are pleased to be able to extend care to our patients in Israeli who are i

TUCSON, Ariz., March 23, 2020 /PRNewswire/ -- In a letter to President Donald Trump, the Associat

SOUTH SAN FRANCISCO, Calif., March 23, 2020 /PRNewswire/ -- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of serious fibrotic diseases, today announced that it has dosed the first cohort of healthy participants in a first-in-human Phase 1 clinical trial of PLN-1474, a sm

SLOUGH, England and RICHMOND, Va., March 23, 2020 /PRNewswire/ -- Indivior PLC (LON: INDV) today announced the publication of one-year outcomes from a 24-month real-world observational study, RECOVER™ (Remission from Chronic Opioid Use—Studying Environmental and Socio-Economic Factors on Recovery).

NEEDHAM, Mass., March 23, 2020 /PRNewswire/ -- For biopharma companies faced with increasing demand for new biologics, cell and gene therapies, and drug products, Thermo Fisher Scientific is investing more than $475 million in new capabilities and capacity in 2020. This investment, in addition to those made in 2019, brings the total in

WOONSOCKET, R.I., March 23, 2020 /PRNewswire/ -- In recognition of the essential role CVS Health (NYSE: CVS) employees are playing as the country faces the COVID-19 pandemic, the company is awarding bonuses to employees who are required to be at CVS facilities to assist patients and customers in this time of unprecedented need. Bonuses will range from

PALO ALTO,  Calif., March 23, 2020 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (Nasdaq: EIGR), focused on the development and commercialization of targeted therapies for serious rare and ultra-rare diseases, today announced that it has completed submission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for lonafarnib for the treatment of Pro

CAMBRIDGE, Mass., March 23, 2020 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of t

CARLSBAD, Calif., March 23, 2020 /PRNewswire/ -- Argonaut Manufacturing Services announced today it has immediate availability for aseptic drug product manufacturing fill/finish service.  Argonaut will provide services for Pre-clinical to Phase III drug product manufacturing of vaccines and therapeutics, including those for sponsors working toward a COVID-19 v